These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24913713)

  • 1. Selective immunoproteasome inhibitors with non-peptide scaffolds identified from structure-based virtual screening.
    Kasam V; Lee NR; Kim KB; Zhan CG
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3614-7. PubMed ID: 24913713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.
    Ettari R; Zappalà M; Grasso S; Musolino C; Innao V; Allegra A
    Pharmacol Ther; 2018 Feb; 182():176-192. PubMed ID: 28911826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of selective fragment-sized immunoproteasome inhibitors.
    Kollár L; Gobec M; Szilágyi B; Proj M; Knez D; Ábrányi-Balogh P; Petri L; Imre T; Bajusz D; Ferenczy GG; Gobec S; Keserű GM; Sosič I
    Eur J Med Chem; 2021 Jul; 219():113455. PubMed ID: 33894528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Early Clinical Development of Selective Immunoproteasome Inhibitors.
    Kirk CJ; Muchamuel T; Wang J; Fan RA
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Evaluation of Highly Selective Human Immunoproteasome Inhibitors Reveal a Compensatory Process That Preserves Immune Cell Viability.
    Ladi E; Everett C; Stivala CE; Daniels BE; Durk MR; Harris SF; Huestis MP; Purkey HE; Staben ST; Augustin M; Blaesse M; Steinbacher S; Eidenschenk C; Pappu R; Siu M
    J Med Chem; 2019 Aug; 62(15):7032-7041. PubMed ID: 31283222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors.
    Maccari R; Ettari R; Adornato I; Naß A; Wolber G; Bitto A; Mannino F; Aliquò F; Bruno G; Nicolò F; Previti S; Grasso S; Zappalà M; Ottanà R
    Bioorg Med Chem Lett; 2018 Feb; 28(3):278-283. PubMed ID: 29292224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biochemical Evaluation of Warhead-Decorated Psoralens as (Immuno)Proteasome Inhibitors.
    Schiffrer ES; Proj M; Gobec M; Rejc L; Šterman A; Mravljak J; Gobec S; Sosič I
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33445542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i).
    Klein M; Busch M; Friese-Hamim M; Crosignani S; Fuchss T; Musil D; Rohdich F; Sanderson MP; Seenisamy J; Walter-Bausch G; Zanelli U; Hewitt P; Esdar C; Schadt O
    J Med Chem; 2021 Jul; 64(14):10230-10245. PubMed ID: 34228444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
    Villoutreix BO; Khatib AM; Cheng Y; Miteva MA; Maréchal X; Vidal J; Reboud-Ravaux M
    Oncotarget; 2017 Feb; 8(6):10437-10449. PubMed ID: 28060729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of isoquinolinone derivatives as immunoproteasome inhibitors.
    Ettari R; Iraci N; Di Chio C; Previti S; Danzè M; Zappalà M
    Bioorg Med Chem Lett; 2022 Jan; 55():128478. PubMed ID: 34838650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening.
    Scarpino A; Bajusz D; Proj M; Gobec M; Sosič I; Gobec S; Ferenczy GG; Keserű GM
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31315311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases.
    Xi J; Zhuang R; Kong L; He R; Zhu H; Zhang J
    Eur J Med Chem; 2019 Nov; 182():111646. PubMed ID: 31521028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors.
    Besse L; Besse A; Kraus M; Maurits E; Overkleeft HS; Bornhauser B; Bourquin JP; Driessen C
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.
    Kollár L; Gobec M; Proj M; Smrdel L; Knez D; Imre T; Gömöry Á; Petri L; Ábrányi-Balogh P; Csányi D; Ferenczy GG; Gobec S; Sosič I; Keserű GM
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome.
    Basler M; Maurits E; de Bruin G; Koerner J; Overkleeft HS; Groettrup M
    Br J Pharmacol; 2018 Jan; 175(1):38-52. PubMed ID: 29034459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.
    Singh PK; Fan H; Jiang X; Shi L; Nathan CF; Lin G
    ChemMedChem; 2016 Oct; 11(19):2127-2131. PubMed ID: 27561172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of the immunoproteasome: current status and future directions.
    Miller Z; Ao L; Kim KB; Lee W
    Curr Pharm Des; 2013; 19(22):4140-51. PubMed ID: 23181576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress on selective immunoproteasome inhibitors].
    Kong L; Lu J; Zhu H; Zhang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 48(6):688-694. PubMed ID: 31955545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells.
    Ettari R; Pallio G; Pizzino G; Irrera N; Zappalà M; Maiorana S; Di Chio C; Altavilla D; Squadrito F; Bitto A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1307-1313. PubMed ID: 31307247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
    Sosič I; Gobec M; Brus B; Knez D; Živec M; Konc J; Lešnik S; Ogrizek M; Obreza A; Žigon D; Janežič D; Mlinarič-Raščan I; Gobec S
    Angew Chem Int Ed Engl; 2016 May; 55(19):5745-8. PubMed ID: 27037901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.